InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Fitzgerald Joseph Michael, Directeur Exécutif et Président. Insider active across 2 companies, notably Boston Scientific CORP. Aggregated, 11 disclosures have been published. The latest transaction was disclosed on 17 November 2025 — C. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
US$724,64227,880 shares@ US$25.99150.30% mcap100.0% of flow
Class A Common Stock
SEC:0002036848-26-000004·
€724,64227,880 shares@ €25.99150.30% mcap50.0% of flow
Class A Common Stock
SEC:0002036848-26-000004:0·
03,603 shares0
Common Stock
SEC:0001225208-22-004296:0·
03,895 shares0
Common Stock
SEC:0001225208-22-003078:0·
04,166 shares0
Common Stock
SEC:0001225208-22-002918:0·
02,780 shares0
Common Stock
SEC:0001225208-22-002669:0·
02,780 shares0
Common Stock
SEC:0001225208-22-002669·
014,035 shares0
Common Stock
SEC:0001225208-22-000110·
014,035 shares0
Common Stock
SEC:0001225208-22-000110:0·
012,000 shares0
Common Stock
SEC:0001225208-21-010900·
012,000 shares0
Common Stock
SEC:0001225208-21-010900:0·
11 of 11 declarations
About Fitzgerald Joseph Michael
Joseph Michael Fitzgerald is the Executive Vice President and President of Interventional Cardiology and Cardiology at Boston Scientific Corp. He oversees the operations of these divisions and is responsible for implementing growth strategies. His expertise in the medical sector contributes to innovation and treatment improvement. As a member of the management team, he plays a key role in the strategic direction of the organization's medical activities.
